Synthesis and resolution of (±)-N-[1-methyl-4-(3-methylbenzyl)hexahydro-1H-1,4-diazepin-6-yl]-1H-indazole -3-carboxamide by preferential crystallization

Tetrahedron Asymmetry

Volumn 8, Issue 14, 1997, Pages 2367-2374

  Harada, Hiroshi ^a   Morie, Toshiya ^a   Hirokawa, Yoshimi ^a   Kato, Shiro ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; SEROTONIN 3 ANTAGONIST;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DRUG SOLUBILITY; DRUG SYNTHESIS; ENANTIOMER; INFRARED SPECTROPHOTOMETRY; PRIORITY JOURNAL; RACEMIC MIXTURE; X RAY DIFFRACTION;

EID: 0030761769     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0957-4166(97)00248-6     Document Type: Article

References (19)

1. a) Richardson, B. P.; Engel, G. Trends Neurosci., 1986, 9, 424-428;
2. b) Bradley, P. B.; Engel, G.; Feniuk, W.; Fozard, J. R.; Humphrey, P. P. A.; Middlemiss, N. D.; Mylecharane, E. J.; Richardson, B. P.; Saxena, P. R. Neuropharmacology, 1986, 25, 563-576;
3. c) Peroutka, S. J. Trends Neurosci., 1988, 11, 496-500;
4. d) Clarke, D. E.; Graig, D. A.; Fozard, J. R. Trends Pharmacol. Sci., 1989, 10, 385-386.
5. a) Peroutka, S. J. Annu. Rev. Neurosci., 1988, 11, 45-60;
6. 3 Receptor Antagonists. In 5-Hydroxytryptamine-3 Receptor Antagonists, King, F. D.; Jones, B. J.; Sanger, G. J. Eds., CRC Press Inc., 1994; pp. 1-43.
7. Plosker, G. L.; Goa, K. L. Drugs, 1991, 42, 805-824.
8. Miyata, K.; Kamato, T.; Nishida, A.; Ito, H.; Yuki, H.; Yamano, M.; Tsutsumi, R.; Katsuyama, Y.; Honda, K. J. Pharmacol. Exp. Ther., 1992, 261, 291-303.
9. a) Cooper, S. J.; Abbott, A. Trends Pharmacol. Sci., 1988, 9, 269-271;
10. b) Roca, J.; Artaiz, I.; Del Río, J. Exp. Opin. Invest. Drugs, 1995, 4, 333-342;
11. c) 5-Hydroxytryptamine-3 Receptor Antagonists, King, F. D.; Jones, B. J.; Sanger, G. J. Eds., CRC Press Inc., 1994.
12. Yoshida, N.; Omoya, H.; Kato, S.; Ito, T. Eur. J. Pharmacol., 1992, 276, 435-440.
13. Kato, S.; Morie, T.; Ito, T.; Yoshida, N. Jpn. Kokai Tokkyo Koho JP 05,230,057 [93,230,57] [Chem. Abstr., 1994, 120, 164242c].
14. Collet, A.; Brienne, M-J.; Jacques, J. Chem. Rev., 1980, 80, 215-230.
15. Harada, H.; Morie, T.; Hirokawa, Y.; Kato, S. Chem. Pharm. Bull., 1996, 44, 2205-2212.
16. Yoshida, T.; Matsuura, N.; Yamamoto, K.; Doi, M.; Shimada, K.; Morie, T.; Kato, S. Heterocycles, 1996, 43, 2701-2712 and references cited therein.
17. The degree of supersaturation (%) was calculated from the equation below, where W is the weight (g) of acetone, d (0.791) is specific gravity of acetone, and S (31.45 mg/ml) is the solubility of the racemate (±)-1 in acetone at 25°C. % = 10.0 × 1000/W/d ×S × 100
18. Brook, P. R.; Ramage, G. R. J. Chem. Soc., 1955, 896-900.
19. Jucker, E.; Rissi, E. Helv. Chim. Acta, 1962, 45, 2383-2403.